Literature DB >> 10375392

Oxidative modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans.

H Arai1, S Kashiwagi, Y Nagasaka, K Uchida, Y Hoshii, K Nakamura.   

Abstract

The mechanism of metal ion-catalyzed oxidative modification of apolipoprotein E (apoE) in human very-low-density lipoprotein (VLDL) and its inhibition by glycosaminoglycan (GAG) was investigated in vitro. The VLDL oxidation catalyzed by Cu2+ led to the lipid peroxidation, the formation of aggregates, and covalent modification of apoE. The modified apoE lost heparin-binding activity. These results suggest that the lipid peroxidation of VLDL and modification of apoE cause impairment of lipid uptake by cells and deposit the oxidized lipids in the tissues. The lipid peroxidation and oxidative modification of apoE in VLDL mediated by Cu2+ and an aqueous radical generator were suppressed by GAG, heparan sulfate, heparin, and chondroitin sulfate A, even though GAGs demonstrated no ability to scavenge alpha,alpha-diphenyl-beta-picrylhydrazyl radical. There were no relationships between inhibitory activity of GAGs in the VLDL oxidation and their number of sulfate groups which possess chelating activity of metal ion. Therefore, it can be considered that the inhibition of VLDL oxidation by GAGs is possibly due to the interaction between GAG and VLDL which bring about the steric hindrance, interference with the reaction between VLDL particle and the reactive oxygen species. These studies suggest that GAGs preserve the biological functions of apoE from oxidative stress. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375392     DOI: 10.1006/abbi.1999.1222

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

Authors:  Joshua B Owen; Rukhsana Sultana; Christopher D Aluise; Michelle A Erickson; Tulin O Price; Guojun Bu; William A Banks; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2010-10-07       Impact factor: 7.376

2.  Effects of oxidation on structural stability and remodeling of human very low density lipoprotein.

Authors:  Madhumita Guha; Olga Gursky
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

3.  Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Authors:  David A Elliott; Cyndi Shannon Weickert; Brett Garner
Journal:  Clin Lipidol       Date:  2010-08-01

Review 4.  Glycosaminoglycans in Neurodegenerative Diseases.

Authors:  Weihua Jin; Fuming Zhang; Robert J Linhardt
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

5.  Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.

Authors:  David A Elliott; Glenda M Halliday; Brett Garner
Journal:  BMC Neurosci       Date:  2010-02-20       Impact factor: 3.288

6.  Glycosaminoglycans reduce oxidative damage induced by copper (Cu+2), iron (Fe+2) and hydrogen peroxide (H2O2) in human fibroblast cultures.

Authors:  Giuseppe M Campo; Angela D'Ascola; Angela Avenoso; Salvatore Campo; Alida M Ferlazzo; Carmelo Micali; Laura Zanghì; Alberto Calatroni
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

7.  Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells.

Authors:  Hong Zhao; Toshiki Tanaka; Vadim Mitlitski; Julie Heeter; Endre A Balazs; Zbigniew Darzynkiewicz
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

8.  Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E.

Authors:  Shiori Tamamizu-Kato; Jason Yiu Wong; Vikram Jairam; Koji Uchida; Vincent Raussens; Hiroyuki Kato; Jean-Marie Ruysschaert; Vasanthy Narayanaswami
Journal:  Biochemistry       Date:  2007-06-20       Impact factor: 3.162

9.  The antioxidant activity of chondroitin-4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-kappaB and caspase activation.

Authors:  G M Campo; A Avenoso; S Campo; G Nastasi; P Traina; A D'Ascola; C A Rugolo; A Calatroni
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

10.  Association between Human Plasma Chondroitin Sulfate Isomers and Carotid Atherosclerotic Plaques.

Authors:  Elisabetta Zinellu; Antonio Junior Lepedda; Antonio Cigliano; Salvatore Pisanu; Angelo Zinellu; Ciriaco Carru; Pietro Paolo Bacciu; Franco Piredda; Anna Guarino; Rita Spirito; Marilena Formato
Journal:  Biochem Res Int       Date:  2011-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.